Here’s What Analysts Are Saying About Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is 1 of the champion immunotherapy stocks to bargain according to hedge funds. RBC Capital reiterated a Hold standing connected Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) connected February 10, mounting a terms people of $745.00.

The aforesaid day, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) highlighted its expanding immunology portfolio and pipeline, announcing that 36 abstracts crossed its immunology and inflammation portfolio and pipeline would beryllium presented astatine the 2026 American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting acceptable to beryllium held February 27 to March 2 successful Philadelphia, Pennsylvania.

Management reported that highlights see the archetypal presentations from the caller Phase 3 allergen-specific programs exhibiting the imaginable of a first-in-class attack to addressing burdensome ocular symptoms successful adults with feline and birch allergies. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) further stated that New Dupixent® analyses crossed dermatological, respiratory, and gastrointestinal diseases would besides beryllium presented, successful collaboration with Sanofi.

In different development, Guggenheim lifted the terms people connected Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $975 from $865 connected February 9, maintaining a bullish outlook with a Buy rating. The steadfast updated its exemplary connected the institution aft its earnings, and told investors that it sees cardinal upcoming catalysts for the company, including the fianlimab/Libtayo LAG-3 information successful melanoma, an FDA determination for the Eylea HD pre-filled syringe successful Q2, and an NDA submission for cemdisiran successful generalized myasthenia gravis successful Q1.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is simply a pharmaceutical institution that develops, discovers, and commercializes therapies for respective diseases, including cancer, oculus disorders, and allergic conditions.

While we admit the imaginable of REGN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.